Literature DB >> 24266376

The merit of medicinal mushrooms from a pharmaceutical point of view.

Ulrike Lindequist1.   

Abstract

Whereas pharmaceuticals prepared by extraction of medicinal plants constitute an important part of evidence-based medicine also in the Western Hemisphere, medicinal mushrooms are mainly used as dietary supplements without declaration of a medical indication. Scientific investigations and case studies from Asian medicine show that fungi have very promising pharmacological potential. This article provides an overview of the principles of authorization and market access of herbal drugs in Europe, with special reference to Germany. The current status regarding mushrooms is reported, with an aim toward supporting the development of legalized pharmaceutical preparations of medicinal mushrooms in Europe.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24266376     DOI: 10.1615/intjmedmushr.v15.i6.10

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  2 in total

1.  Evaluation of Antioxidant, Anti-cholinesterase, and Anti-inflammatory Effects of Culinary Mushroom Pleurotus pulmonarius.

Authors:  Trung Kien Nguyen; Kyung Hoan Im; Jaehyuk Choi; Pyung Gyun Shin; Tae Soo Lee
Journal:  Mycobiology       Date:  2016-12-31       Impact factor: 1.858

2.  FIP-nha, a fungal immunomodulatory protein from Nectria haematococca, induces apoptosis and autophagy in human gastric cancer cells via blocking the EGFR-mediated STAT3/Akt signaling pathway.

Authors:  Shu-Ying Li; Li-Zhen Hou; Ya-Xin Gao; Na-Na Zhang; Bei Fan; Fengzhong Wang
Journal:  Food Chem (Oxf)       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.